High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S.
Production problems and a brief pause on its use kept the one-dose vaccine from becoming the game changer that health officials across the country believed it would be.
View original article
Contributor: Noah Weiland
